Title of Collaborative Activity: |
Sequencing Quality Control Phase 2 (SEQC2) |
Description of Collaborative Activity: |
The Sequencing Quality Control (SEQC) consortium is an FDA-led community-wide effort. SEQC2 is a project within the consortium. SEQC2 goals: (1) to develop quality metrics for reproducible NGS results from both whole genome sequencing (WGS) and targeted gene sequencing (TGS), (2) to benchmark bioinformatics methods for WGS and TGS towards the development of standard data analysis protocols, and (3) to assess the joint effects of key parameters affecting NGS results and interpretation for clinical application. NLM/NCBI provides an NCBI data portal for and contributes data analysis to this effort. |
Type of Collaborative Activity: |
Resource Development
|
Year the Collaborative Activity Originated: |
2017 |
NIH Participating Institutes/Centers/Office of the Director: |
NLM, CIT, NCI, NHLBI, NIEHS |
HHS Agency Collaborators on this Activity: |
FDA |
